FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule


Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Circulatory System Devices Panel

December 7-8, 2006

Robert A. Harrington, M.D.

  • 18 U.S.C. 208 waiver (pdf)

JoAnn Lindenfeld, M.D.

  • 18 U.S.C. 208 waiver (pdf)

Richard L. Page, M.D.

  • 18 U.S.C. 208 waiver (pdf)

George W. Vetrovec, M.D.

  • 18 U.S.C. 208 waiver (pdf)

Judah Z. Weinberger, M.D., Ph.D.

On December 1st, Dr. Weinberger informed FDA that this financial interest no longer exists. As such, a waiver is not necessary to authorize his participation in the meeting. (Updated 12/4/2006)

  • 18 U.S.C. 208 waiver (pdf)

Clyde W. Yancy, M.D.

  • 18 U.S.C. 208 waiver (pdf)

Page updated: December 4, 2006